India vulnerable to second wave of coronavirus: AIIMS director
Thursday, 25 June 2020 () AIIMSdirector Randeep Guleria said India is also vulnerable to second wave of coronavirus and people should continue to follow social distancing, wearing mask and other precautions, after cases begin to decline.
All India Institute of Medical Sciences Director Randeep Guleria on June 27 reacted on surging COVID-19 cases in the country. He said that the rise in COVID cases in country are not that high if compared to countries affected from the invisible enemy and India has low mortality rate. He said, "Rise in cases in India is still not as high as compared to other countries. In US, there've been almost 40,000 cases per day in last 2 days, our numbers aren't that high. Cases per million population continue to be low and we still have low mortality rate."
The Director of All India Institute of Medical Sciences, (AIIMS), Dr Randeep Guleria said on June 12 that India is still very low in terms of number of cases of coronavirus, if one looks at number of cases per million population. "Although India has gone up to the 4th rank as far as COVID-19 cases are concerned, we have to accept that it is because of the population we have. If we look at number of cases per million population, we still are very low in terms of number of cases," said Dr Randeep Guleria.
The Director of All India Institute of Medical Sciences, (AIIMS), Dr Randeep Guleria reacted over Delhi's Deputy Chief Minister Manish Sisodia's statement that 5.5 lakh cases are expected in the national capita by July 31. "Number of cases in Delhi may not be as high as predicted but still whatever be the number, we have to increase our capacity so that we can manage increasing load that healthcare system is going to get," he said.
Director of All India Institute of Medical Sciences (AIIMS) Delhi, Dr Randeep Guleria said that there are higher chances of toxicity if Hydroxychloroquine (HCQ) used as part of treatment for severe COVID-19 patients because of multiple drugs being used. Being asked about his opinion on WHO 'temporarily' suspending clinical trials of HCQ for COVID-19, Dr Guleria said, "There are 2 different aspects, using Hydroxychloroquine as part of treatment for severe COVID-19 patients has higher chance that you may have toxicity because of multiple drugs being used. And there are certain drugs which along with hydroxychloroquine can increase the chance of cardiac toxicity. On the other hand, when we are giving it as prophylaxis or in mild illness and giving it alone the chances of side effects are much less. We, as physicians have been using hydroxychloroquine for almost 30-40 years. Patients have been using it daily, not for week but for months and years with no side effects. So, when it is used judiciously, appropriately and not in combination with other drugs where the side effects can become much more, there is good suggestive data that suggests it is useful."
Dead bodies of two patients belonging to two different communities were swapped at All India Institute of Medical Sciences (AIIMS) on July 06. Daughter of the deceased said, "We received a call from AIIMS, and the staff member told us that by mistake they have given someone else's body to us. My mother's body was still in the hospital. The body which we received belonged to a Muslim family." The body of the Muslim woman was cremated following Hindu customs.
Protest by the AIIMS Nurses' Union over their working condition entered the third day on Wednesday as the number of workers infected by Covid-19 at the premier... IndiaTimes Also reported by •Indian Express •Hindu
MADURAI Revenue Minister R.B. Udayakumar said construction of the All India Institute of Medical Sciences (AIIMS) at Thoppur here had not been affecte Hindu Also reported by •Indian Express •IndiaTimes